Full Text View
Tabular View
No Study Results Posted
Related Studies
Open Label Study for the Evaluation of Tolerability of Five Dose Levels of Cand5
This study has been completed.
Study NCT00722384   Information provided by Opko Health, Inc.

First Received on July 23, 2008.   Last Updated on July 24, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Macular Degeneration
More general conditions related to this trial
Eye Diseases
Retinal Degeneration
Retinal Diseases
Interventions listed in this trial
bevasiranib
Sponsors listed in this trial
Opko Health, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services